z-logo
open-access-imgOpen Access
A Pilot Split-face Comparison of Q-switched (QS) Single Pulse versus QS Quick Pulse-to-pulse 1,064-nm Nd:YAG Laser Treatment in a Patient with Melasma
Author(s) -
Sung Bin Cho,
Jin-Soo Kang,
Boncheol Goo
Publication year - 2013
Publication title -
medical lasers
Language(s) - English
Resource type - Journals
eISSN - 2288-0224
pISSN - 2287-8300
DOI - 10.25289/ml.2013.2.2.76
Subject(s) - melasma , laser , pulse (music) , erythema , medicine , dermatology , q switching , laser treatment , optics , materials science , nuclear medicine , physics , detector
Melasma is a common disorder that clinically presents as symmetric illdefined hyperpigmented macules and patches on the face. In the current split-face, evaluator-blinded study, we treated a female patient with eight sessions of 1,064-nm Nd:YAG laser treatment at one-week intervals. Utilizing the Q-switched (QS) quick pulse-to-pulse (Q-PTP) mode, in reference to the laser settings, 1,064-nm Nd:YAG laser energy can be irradiated at split fluences and at a dual-pulse interval of 80-μsec. On the right side of the face, 1,064-nm QS single pulse Nd:YAG laser treatment was administered with the settings of 1.6 J/cm2, a spot size of 7-mm, and 1200 shots. On the left side, 1,064-nm QS Q-PTP Nd:YAG laser treatment was administered with the settings of 1.6 J/cm2 irradiated at dual pulses of 0.8 J/cm2 at 80-μsec intervals, a spot size of 7-mm, and 1,200 shots. Results of objective clinical assessment showed better clinical outcomes with less treatment-associated pain with QS Q-PTP-treatment than with QS single-pulse-treatment. However, clinical outcomes were subjectively indistinguishable between QS single pulseand QS Q-PTP-treatments. Transient or persistent post-treatment erythema and newly developed punctate leukoderma lesions were not reported for either side of the face. Pre-existing punctate leukoderma lesions became obscure, especially on the QS Q-PTP-treated side, with improvement of the melasma lesions. We suggest that the QS Q-PTP mode may be of use in treatment of melasma, particularly on the relatively thin skin of the periorbital regions and in pain-sensitive and erythema-prone patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom